Statistical analysis on ADAS-cog was performed using all available on-treatment data. Beginning with Month 3, there were 127 subjects in the placebo group and 126 subjects in the 5 mg/day dose group ...
Compared with sham treatment, personalised repetitive transcranial magnetic stimulation (rTMS) of the precuneus over 52 weeks led to a reduction in cognitive decline by 52% and functional decline by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results